Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study ...

Considering a change to your treatment regimen? Columnist Mary Shaniqua shares tips to help patients and providers make an ...

Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a ...

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...

To mark four years of sharing his experiences through writing, columnist Dunstan Nicol-Wilson reflects on the journey with gratitude.

Columnist Oluwatosin Adesoye shares her thoughts about the role of World Sickle Cell Day in promoting sickle cell awareness.

Sickle Cell Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for ...

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

Casgevy (exagamglogene autotemcel), formerly known as CTX001 or exa-cel, is an approved gene-editing therapy used for people with SCD who experience recurrent vaso-occlusive crises. It is designed to ...

One can read the biological explanations of such a crisis, but can’t really understand what it feels like without having the disease. So, it is only natural for people to wonder about it. I’m ...